Clinical trials, cancer

Also known as: Cancer clinical trials
Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose, or treat disease. The purpose of a clinical trial is to find out whether a medicine or treatment regimen is safe and effective for the treatment of a specific condition or disease. Clinical trials compare the effectiveness of the study medicine or treatment against standard, accepted treatment, or against a placebo if no standard treatment exists. See a list of current cancer clinical trials available at Providence.

At Providence Cancer Center, our scientists and clinicians work closely together to improve the standard of care through the integration of clinical trials into clinical practice. Our clinical trials include Robert W. Franz Cancer Research Center investigator initiated studies, National Cancer Institute (NCI) sponsored studies and pharmaceutical sponsored studies. The clinical trials team at Providence Cancer Center works directly with referring providers and their patients to find the most appropriate clinical trial(s) that fit their specific diagnosis.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ask An Expert

Ipilimumab among treatment advances for metastatic melanoma

Many different systemic therapies have been tested for melanoma over the past 50 years, with generally disappointing results. The phase 3 study of ipilimumab was the first to show a survival benefit for any medical therapy in melanoma. – By Brendan Curti, M.D., medical director, Providence Biotherapy Program, Providence Melanoma Program

Forms Instructions

Prostate cancer research gets a boost

Prostate cancer, once it spreads to lymph nodes and bones, generally is not curable. But basic and clinical researchers at Providence are working on this challenge.

Proprietary Health Article

Advances in prostate cancer immunotherapy at Providence

As knowledge about the immune system explodes, so does the potential of innovative treatments. – By Brendan Curti, M.D., medical director, Providence Genitourinary Oncology Research

Breast cancer chemoprevention in the spotlight again

After a tentative start, chemopreventive therapies might return to the forefront.  A recent international study reports promising results. – By Ali Conlin, M.D., medical oncologist

Vitamin D and breast cancer: Is there a link?

Studies have provided conflicting results, but here’s what we know so far. – By Ali Conlin, M.D., medical oncologist

Recommended Resource

American Cancer Society

American Cancer Society’s home page with links to all types of cancer, symptoms, treatment options, statistics trials and ways to contribute. 

ClinicalTrials.gov

ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.

ClinicalTrials.gov Frequently Asked Questions

Choosing to participate in a clinical trial is an important personal decision. The following frequently asked questions provide detailed information about clinical trials. In addition, it is often helpful to talk to a physician, family members, or friends about deciding to join a trial. After identifying some trial options, the next step is to contact the study research staff and ask questions about specific trials.

Columbia River Oncology Program

The Columbia River Oncology Program is a Community Clinical Oncology Program (CCOP) opened in 1987 and is managed by NCI. Consortium affiliates include health care systems and providers in the metropolitan areas of Portland, Ore., and Vancouver, Wash.

National Cancer Institute Physician Data Query

The National Cancer Institute’s comprehensive cancer database contains summaries on a wide range of cancer topics, a registry of more than 8,000 open and 19,000 closed cancer clinical trials from around the world and a directory of professionals who provide genetics services.

National Institutes of Health Office of Rare Diseases Research: Research and clinical trials

Links to Federal and non-federal information about research into rare diseases including ORDR-supported research. When you enter most of the Web sites listed below, you will leave the ORDR Web site. Please return to find more information about research resources, scientific conferences, genetics information and services, and other related information.

Latest News

View All